|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Politi K and Herbst RS: Lung cancer in the
era of precision medicine. Clin Cancer Res. 21:2213–2220. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Rubinsztein DC, Gestwicki JE, Murphy LO
and Klionsky DJ: Potential therapeutic applications of autophagy.
Nat Rev Drug Discov. 6:304–312. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Karsli-Uzunbas G, Guo JY, Price S, Teng X,
Laddha SV, Khor S, Kalaany NY, Jacks T, Chan CS, Rabinowitz JD, et
al: Autophagy is required for glucose homeostasis and lung tumor
maintenance. Cancer Discov. 4:914–927. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Egan DF, Chun MG, Vamos M, Zou H, Rong J,
Miller CJ, Lou HJ, Raveendra-Panickar D, Yang CC, Sheffler DJ, et
al: Small molecule inhibition of the autophagy kinase ULK1 and
identification of ULK1 substrates. Mol Cell. 59:285–297. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Guo JY, Xia B and White E:
Autophagy-mediated tumor promotion. Cell. 155:1216–1219. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Fung C, Chen X, Grandis JR and Duvvuri U:
EGFR tyrosine kinase inhibition induces autophagy in cancer cells.
Cancer Biol Ther. 13:1417–1424. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Li X, Lu Y, Pan T and Fan Z: Roles of
autophagy in cetuximab-mediated cancer therapy against EGFR.
Autophagy. 6:1066–1077. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chan EY, Kir S and Tooze SA: siRNA
screening of the kinome identifies ULK1 as a multidomain modulator
of autophagy. J Biol Chem. 282:25464–25474. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ganley IG, Lam H, Wang J, Ding X, Chen S
and Jiang X: ULK1.ATG13.FIP200 complex mediates mTOR signaling and
is essential for autophagy. J Biol Chem. 284:12297–12305. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liu CC, Lin YC, Chen YH, Chen CM, Pang LY,
Chen HA, Wu PR, Lin MY, Jiang ST, Tsai TF, et al: Cul3-KLHL20
ubiquitin ligase governs the turnover of ULK1 and VPS34 complexes
to control autophagy termination. Mol Cell. 61:84–97. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Pike LR, Singleton DC, Buffa F, Abramczyk
O, Phadwal K, Li JL, Simon AK, Murray JT and Harris AL:
Transcriptional up-regulation of ULK1 by ATF4 contributes to cancer
cell survival. Biochem J. 449:389–400. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yun M, Bai HY, Zhang JX, Rong J, Weng HW,
Zheng ZS, Xu Y, Tong ZT, Huang XX, Liao YJ, et al: ULK1: A
promising biomarker in predicting poor prognosis and therapeutic
response in human nasopharygeal carcinoma. PLoS One.
10:e01173752015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tang J, Deng R, Luo RZ, Shen GP, Cai MY,
Du ZM, Jiang S, Yang MT, Fu JH and Zhu XF: Low expression of ULK1
is associated with operable breast cancer progression and is an
adverse prognostic marker of survival for patients. Breast Cancer
Res Treat. 134:549–560. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zou Y, Chen Z, He X, He X, Wu X, Chen Y,
Wu X, Wang J and Lan P: High expression levels of unc-51-like
kinase 1 as a predictor of poor prognosis in colorectal cancer.
Oncol Lett. 10:1583–1588. 2015.PubMed/NCBI
|
|
16
|
Jiang S, Li Y, Zhu YH, Wu XQ, Tang J, Li
Z, Feng GK, Deng R, Li DD, Luo RZ, et al: Intensive expression of
UNC-51-like kinase 1 is a novel biomarker of poor prognosis in
patients with esophageal squamous cell carcinoma. Cancer Sci.
102:1568–1575. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Stewart SA, Dykxhoorn DM, Palliser D,
Mizuno H, Yu EY, An DS, Sabatini DM, Chen IS, Hahn WC, Sharp PA, et
al: Lentivirus-delivered stable gene silencing by RNAi in primary
cells. RNA. 9:493–501. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Fung C, Lock R, Gao S, Salas E and Debnath
J: Induction of autophagy during extracellular matrix detachment
promotes cell survival. Mol Biol Cell. 19:797–806. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Győrffy B, Surowiak P, Budczies J and
Lánczky A: Online survival analysis software to assess the
prognostic value of biomarkers using transcriptomic data in
non-small-cell lung cancer. PLoS One. 8:e822412013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sakuma Y, Yamazaki Y, Nakamura Y,
Yoshihara M, Matsukuma S, Nakayama H, Yokose T, Kameda Y, Koizume S
and Miyagi Y: WZ4002, a third-generation EGFR inhibitor, can
overcome anoikis resistance in EGFR-mutant lung adenocarcinomas
more efficiently than Src inhibitors. Lab Invest. 92:371–383. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Shen M, Duan WM, Wu MY, Wang WJ, Liu L, Xu
MD, Zhu J, Li DM, Gui Q, Lian L, et al: Participation of autophagy
in the cytotoxicity against breast cancer cells by cisplatin. Oncol
Rep. 34:359–367. 2015.PubMed/NCBI
|
|
22
|
Huang Y, Guerrero-Preston R and Ratovitski
EA: Phospho-∆Np63α-dependent regulation of autophagic signaling
through transcription and micro-RNA modulation. Cell Cycle.
11:1247–1259. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ren JH, He WS, Nong L, Zhu QY, Hu K, Zhang
RG, Huang LL, Zhu F and Wu G: Acquired cisplatin resistance in
human lung adenocarcinoma cells is associated with enhanced
autophagy. Cancer Biother Radiopharm. 25:75–80. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sui X, Chen R, Wang Z, Huang Z, Kong N,
Zhang M, Han W, Lou F, Yang J, Zhang Q, et al: Autophagy and
chemotherapy resistance: A promising therapeutic target for cancer
treatment. Cell Death Dis. 4:e8382013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Russell RC, Tian Y, Yuan H, Park HW, Chang
YY, Kim J, Kim H, Neufeld TP, Dillin A and Guan KL: ULK1 induces
autophagy by phosphorylating Beclin-1 and activating VPS34 lipid
kinase. Nat Cell Biol. 15:741–750. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Di Bartolomeo S, Corazzari M, Nazio F,
Oliverio S, Lisi G, Antonioli M, Pagliarini V, Matteoni S, Fuoco C,
Giunta L, et al: The dynamic interaction of AMBRA1 with the dynein
motor complex regulates mammalian autophagy. J Cell Biol.
191:155–168. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liu JT, Li WC, Gao S, Wang F, Li XQ, Yu
HQ, Fan LL, Wei W, Wang H and Sun GP: Autophagy inhibition
overcomes the antagonistic effect between gefitinib and cisplatin
in epidermal growth factor receptor mutant non-small-cell lung
cancer cells. Clin Lung Cancer. 16:e55–e66. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ettinger DS, Wood DE, Akerley W, Bazhenova
LA, Borghaei H, Camidge DR, Cheney RT, Chirieac LR, D'Amico TA,
Demmy TL, et al: National comprehensive cancer network: Non-small
cell lung cancer, version 6.2015. J Natl Compr Canc Netw.
13:515–524. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Reck M, Heigener DF, Mok T, Soria JC and
Rabe KF: Management of non-small-cell lung cancer: Recent
developments. Lancet. 382:709–719. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
White E: Deconvoluting the
context-dependent role for autophagy in cancer. Nat Rev Cancer.
12:401–410. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Rao S, Tortola L, Perlot T, Wirnsberger G,
Novatchkova M, Nitsch R, Sykacek P, Frank L, Schramek D, Komnenovic
V, et al: A dual role for autophagy in a murine model of lung
cancer. Nat Commun. 5:30562014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Strohecker AM, Guo JY, Karsli-Uzunbas G,
Price SM, Chen GJ, Mathew R, McMahon M and White E: Autophagy
sustains mitochondrial glutamine metabolism and growth of
BrafV600E-driven lung tumors. Cancer Discov. 3:1272–1285. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Joshi A, Iyengar R, Joo JH, Li-Harms XJ,
Wright C, Marino R, Winborn BJ, Phillips A, Temirov J, Sciarretta
S, et al: Nuclear ULK1 promotes cell death in response to oxidative
stress through PARP1. Cell Death Differ. 23:216–230. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Jung CH, Seo M, Otto NM and Kim DH: ULK1
inhibits the kinase activity of mTORC1 and cell proliferation.
Autophagy. 7:1212–1221. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Gao W, Shen Z, Shang L and Wang X:
Upregulation of human autophagy-initiation kinase ULK1 by tumor
suppressor p53 contributes to DNA-damage-induced cell death. Cell
Death Differ. 18:1598–1607. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Mukhopadhyay S, Das DN, Panda PK, Sinha N,
Naik PP, Bissoyi A, Pramanik K and Bhutia SK: Autophagy protein
Ulk1 promotes mitochondrial apoptosis through reactive oxygen
species. Free Radic Biol Med. 89:311–321. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Schaaf MB, Keulers TG, Vooijs MA and
Rouschop KM: LC3/GABARAP family proteins: Autophagy-(un)related
functions. FASEB J. 30:3961–3978. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Tanida I, Ueno T and Kominami E: LC3
conjugation system in mammalian autophagy. Int J Biochem Cell Biol.
36:2503–2518. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Tanida I, Tanida-Miyake E, Ueno T and
Kominami E: The human homolog of Saccharomyces cerevisiae Apg7p is
a Protein-activating enzyme for multiple substrates including human
Apg12p, GATE-16, GABARAP, and MAP-LC3. J Biol Chem. 276:1701–1706.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Rikiishi H: Novel insights into the
interplay between apoptosis and autophagy. Int J Cell Biol.
2012:3176452012. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Adams JM and Cory S: The Bcl-2 apoptotic
switch in cancer development and therapy. Oncogene. 26:1324–1337.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Strasser A and Bouillet P: The control of
apoptosis in lymphocyte selection. Immunol Rev. 193:82–92. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Cory S and Adams JM: The Bcl2 family:
Regulators of the cellular life-or-death switch. Nat Rev Cancer.
2:647–656. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
44
|
Gil J, Ramsey D, Szmida E, Leszczynski P,
Pawlowski P, Bebenek M and Sasiadek MM: The BAX gene as a candidate
for negative autophagy-related genes regulator on mRNA levels in
colorectal cancer. Med Oncol. 34:162017. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Park D, Magis AT, Li R, Owonikoko TK, Sica
GL, Sun SY, Ramalingam SS, Khuri FR, Curran WJ and Deng X: Novel
small-molecule inhibitors of Bcl-XL to treat lung cancer. Cancer
Res. 73:5485–5496. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Wangpaichitr M, Wu C, You M, Kuo MT, Feun
L, Lampidis T and Savaraj N: Inhibition of mTOR restores cisplatin
sensitivity through down-regulation of growth and anti-apoptotic
proteins. Eur J Pharmacol. 591:124–127. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Ro SH, Jung CH, Hahn WS, Xu X, Kim YM, Yun
YS, Park JM, Kim KH, Seo M, Ha TY, et al: Distinct functions of
Ulk1 and Ulk2 in the regulation of lipid metabolism in adipocytes.
Autophagy. 9:2103–2114. 2013. View Article : Google Scholar : PubMed/NCBI
|
